← back to search

Sukhvinder S. Bansal

All India Institute of Medical Sciences · IN
Area of research
Hematology · Genetics · kumar
Research interest
Research interests include Iron Metabolism and Disorders, Hemoglobinopathies and Related Disorders, Chemical Synthesis and Analysis, and Monoclonal and Polyclonal Antibodies Research.
h-index
30
citations
2,616
works
115
NIH funding
primary concept
email

Recent publications

Autopsy-Based Insights Into Maternal Mortality: A Retrospective Study From a Tertiary Care Center in North India.
Cureus 2026cited by 0position: contributordoi
Intravenous iron preparations transiently generate non-transferrin-bound iron from two proposed pathways
Haematologica 2020cited by 40position: middledoi
Temporin L and aurein 2.5 have identical conformations but subtly distinct membrane and antibacterial activities
Scientific Reports 2019cited by 41position: middledoi
Provisional standardization of hepcidin assays: creating a traceability chain with a primary reference material, candidate reference method and a commutable secondary reference material
Clinical Chemistry and Laboratory Medicine (CCLM) 2018cited by 61position: middledoi
Translocation of LRP1 targeted carbon nanotubes of different diameters across the blood–brain barrier in vitro and in vivo
Journal of Controlled Release 2016cited by 143position: middledoi
Toward Worldwide Hepcidin Assay Harmonization: Identification of a Commutable Secondary Reference Material
Clinical Chemistry 2016cited by 84position: middledoi
Carbon nanotubes' surface chemistry determines their potency as vaccine nanocarriers in vitro and in vivo
Journal of Controlled Release 2016cited by 61position: middledoi
Copper(II) binding properties of hepcidin
JBIC Journal of Biological Inorganic Chemistry 2016cited by 36position: lastdoi
Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial
PLoS ONE 2016cited by 32position: middledoi
Effects of intravenous iron on fibroblast growth factor 23 (FGF23) in haemodialysis patients: a randomized controlled trial
BMC Nephrology 2016cited by 32position: middledoi
Passively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo
Small 2015cited by 135position: middledoi
Synthesis of double-clickable functionalised graphene oxide for biological applications
Chemical Communications 2015cited by 55position: middledoi
Mechanisms of plasma non‐transferrin bound iron generation: insights from comparing transfused diamond blackfan anaemia with sickle cell and thalassaemia patients
British Journal of Haematology 2014cited by 66position: middledoi
Conformational Flexibility Determines Selectivity and Antibacterial, Antiplasmodial, and Anticancer Potency of Cationic α-Helical Peptides
Journal of Biological Chemistry 2012cited by 99position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Noelia Rubio · Universidad de Alcalá4 papers (2015–2016)Khuloud T. Al‐Jamal · King's College London4 papers (2015–2016)Robert C. Hider · King's College London3 papers (2015–2020)Julie Wang · Shanghai Jiao Tong University3 papers (2015–2016)A. James Mason · Johns Hopkins University2 papers (2012–2019)John B. Porter · University College Hospital2 papers (2014–2020) · 2 papers (2016–2018)Rebecca Klippstein · King's College London2 papers (2015–2016)Hatem A. F. M. Hassan · Medway School of Pharmacy2 papers (2016–2016) · 2 papers (2016–2018)Kelly R. Pitts · University of Virginia2 papers (2016–2018) · 2 papers (2016–2018)Houmam Kafa · Atomic Energy Commission of Syria2 papers (2015–2016)Dorine W. Swinkels · University Hospital of Zurich2 papers (2016–2018)Tam T. T. Bui · King's College London2 papers (2012–2019)Vincenzo Abbate · King's College London2 papers (2012–2015) · 2 papers (2016–2018)Alex F. Drake · King's College London2 papers (2012–2019)Roger Atkinson · Centre National de la Recherche Scientifique2 papers (2012–2019) · 2 papers (2016–2018)